About this trial
Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028.
Avis-PHAGEinLYON clinic study information notice provided to the patient
Disqualifiers
- Opposition of trial participant
Trial population
1500 patients with severe infection treated with phagotherapy will be included in the study.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Phage therapy requests
Other interventionQuantification of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028
Treatment groups
Trial outcomes
Primary outcomes
Number of phage therapy requests
Number of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028 per year and per month.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.